Fewer radiation sessions could ease brain tumor treatment burden
NCT ID NCT07492836
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This pilot study tests a new radiation schedule for glioblastoma, a serious brain cancer. Instead of standard daily treatments over many weeks, patients receive a higher dose each day for fewer total sessions, combined with the chemotherapy drug temozolomide. The study aims to see if this approach is safe and practical in 10 patients aged 18 to 70.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Hypofractionated radiation therapy and temozolomide chemotherapy
- What this could lead to
- If successful, this could lead to a more convenient treatment option for glioblastoma that reduces the number of hospital visits while maintaining effectiveness.
- What could go wrong
- This is a very small pilot study with only 10 participants, so results may not apply to all patients. The higher daily radiation dose could increase side effects like brain swelling or tissue damage.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA (GBM) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Custom-Made vaccine train the immune system to fight brain cancer?
- Can a virus injected into brain tumors fight recurrence?
- Can adding lenvatinib to standard care outsmart a tough brain cancer?
- Can a pill reach the brain and fight tumors?
- Targeted radiation delivered directly to brain tumor cavity in new trial
- Oxygen-Enhanced MRI could sharpen radiotherapy for deadly brain cancers